Uncategorized - November 29, 2018
Diabetes drug may increase the risk of serious adverse events
According to a Nordic study the use of a new class of drugs in the treatment of type 2 diabetes, so called SGLT2 inhibitors, are linked to a twofold increased risk for lower-limb amputation as well as diabetic ketoacidosis, a serious diabetes complication. Use of the SGLT2 inhibitors (sodium-glucose cotransporter 2) has increased sharply during […]
Global report - November 28, 2018
Chinese scientist claims to have helped make the world’s first genome-edited babies
He Jiankui, a genome-editing researcher at the Southern University of Science and Technology of China in Shenzhen, claims to have impregnated a woman with embryos that had been edited to disable the genetic pathway HIV uses to infect cells. The father of the girls is HIV positive but the mother is not, says He in a […]
Uncategorized - November 21, 2018
New inflammation inhibitor discovered
A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able to reduce the signals that trigger an inflammation. “We’ve developed a new drug molecule that inhibits inflammation,” says Professor Thomas Helleday, at the […]
Uncategorized - November 7, 2018
The appendix could be a starting point for Parkinson’s
A large research study shows that the appendix acts as a reservoir for disease-associated proteins and appendectomy lowers the risk of developing Parkinson’s disease. The study involved scientists from Van Andel Research Institute, Northwestern University, Lund University and Michigan State University, and the results was published recently in Science Translational Medicine. And according to the new study, […]
Uncategorized - October 31, 2018
New cell structure discovered
A new structure in human cells, called reticular adhesions, has been discovered by researchers at Karolinska Institutet in collaboration with colleagues in the UK. The structure is a new type of protein complex that the cell uses to attach to its surroundings and proves to play a key part in cell division. “It’s incredibly surprising […]
Uncategorized - October 18, 2018
24 million SEK to Swedish research on antibiotic resistance & tuberculosis
Fredrik Almqvist, Professor in organic chemistry at Umeå University, and his American research colleague Christina Stallings, receive SEK 24 million from the National Institutes of Health (NIH) for research for combating infections of the most common type of tuberculosis bacteria. “It’s absolutely amazing! A grant of this size really makes a difference and gives us […]
